Connection

Whitney Graybill to Poly(ADP-ribose) Polymerase Inhibitors

Back to Details
This is a "connection" page, showing publications Whitney Graybill has written about Poly(ADP-ribose) Polymerase Inhibitors.
Whitney Graybill
Connection Strength
0.741
Poly(ADP-ribose) Polymerase Inhibitors
  1. Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma. Gynecol Oncol. 2017 07; 146(1):11-15.
    View in: PubMed
    Score: 0.571
  2. Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. N Engl J Med. 2019 12 19; 381(25):2391-2402.
    View in: PubMed
    Score: 0.170
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.